Neurologic manifestations associated with COVID-19: a multicentre registryElodie Meppiel, Thibault Fraisse, Lucas Gorza et al.|Clinical Microbiology and Infection|2020Cited by 142
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisMathilde Lefort, F. Grand’Maison, Sifat Sharmin et al.|BMC Medical Research Methodology|2022Cited by 6